In a tragic incident at Zebar School in Thaltej, an eight-year-old girl passed away after suffering a heart attack on Friday ...

A 60-year-old woman infected with HMPV infection during treatment in Lucknow. Hospital officials have cited other medical ...

Kerendia helps prevent or delay kidney failure in diabetic patients, while Verquvo is designed to reduce hospitalisation rates in patients with worsening heart ... in Bayer Zydus Pharma from ...

Lipid profile, heart health and fitness screening – these are some new ... chief clinical nutritionist at Zydus Hospitals in Ahmedabad, has encountered from her clients. “Now people are coming to me ...

Bayer's expanded therapies and strategic collaborations in India aim to drive pharmaceutical growth amidst regulatory challenges and pricing pressures.

However, they also acknowledged that “the observed incidence rate of NAION of 0.228 per 1000 person-years” for diabetics with once-weekly semaglutide may not discourage its use given its benefits in ...

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS). The designation ...

The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb trial of its oral NLRP3 inflammasome inhibitor, Usnoflast, for ...

Zydus, a leading, discovery-based, global pharmaceutical company announced that the US FDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of ...

Zydus Wellness Ltd announced that its subsidiary, Zydus Wellness Products Ltd, has received a GST demand of Rs 56.33 crore with interest and penalties from the tax authority. The demand relates to ...

Zydus Lifesciences announced that it has entered into an agreement with CVS Caremark, a CVS Health (CVS) company, to add Zituvio, Zituvimet and Zituvimet XR tablets to its template formulary.